Summit Therapeutics Inc. (SMMT)

Summit Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	93.78	71.43	348.61	71.79	66.42	63.84
Short-Term Investments	393.12	114.82	-	-	-	-
Cash & Short-Term Investments	486.9	186.24	348.61	71.79	66.42	63.84
Cash Growth	144.74%	-46.58%	385.59%	8.09%	4.03%	80.92%
Accounts Receivable	-	-	0.35	1.46	0.33	0.54
Other Receivables	0.66	0.85	5.77	15.7	9.86	5.08
Receivables	0.66	0.85	6.12	17.16	10.19	5.63
Prepaid Expenses	2.41	2.44	1.5	7.16	9.55	8.76
Restricted Cash	0.32	-	300	-	-	-
Other Current Assets	-	0.18	0.49	1.2	1.52	1.4
Total Current Assets	490.29	189.71	656.71	97.31	87.67	79.63
Property, Plant & Equipment	8.24	6.06	5.08	3.48	1.28	1.54
Goodwill	1.99	1.89	1.8	2.01	2.03	1.96
Other Intangible Assets	-	-	-	10.4	11.52	13.12
Other Long-Term Assets	2.33	5.28	0.58	0.17	-	-
Total Assets	502.85	202.95	664.17	113.37	102.5	96.25
Accounts Payable	3.25	2.67	0.36	4.37	6.14	4.47
Accrued Expenses	26.44	14.21	16.31	11.32	4.26	5.74
Current Portion of Long-Term Debt	24.5	-	19.77	-	-	-
Current Portion of Leases	3.79	2.81	1.69	1.09	0.39	0.47
Current Unearned Revenue	-	-	-	7.94	8.37	2.62
Other Current Liabilities	1.03	0.72	0.66	0.9	0.73	0.47
Total Current Liabilities	59.01	20.41	38.78	25.62	19.89	13.77
Long-Term Debt	-	100	494.54	-	-	-
Long-Term Leases	4.21	3.29	2.76	1.69	0.08	0.42
Long-Term Unearned Revenue	-	-	-	-	0.57	0.49
Other Long-Term Liabilities	1.72	1.56	1.43	2.78	2.51	2.7
Total Liabilities	64.93	125.26	537.51	30.09	23.05	17.39
Common Stock	7.37	7.02	2.11	0.98	0.83	0.67
Additional Paid-In Capital	1,586	1,066	504.77	384.05	293.37	241.2
Retained Earnings	-1,153	-993.26	-378.33	-299.55	-210.95	-158.25
Comprehensive Income & Other	-2.31	-2.45	-1.89	-2.2	-3.79	-4.76
Shareholders' Equity	437.92	77.69	126.65	83.28	79.45	78.86
Total Liabilities & Equity	502.85	202.95	664.17	113.37	102.5	96.25
Total Debt	32.5	106.1	518.76	2.78	0.47	0.89
Net Cash (Debt)	454.4	80.14	-170.16	69.01	65.95	62.95
Net Cash Growth	392.38%	-	-	4.64%	4.77%	85.33%
Net Cash Per Share	0.64	0.13	-0.88	0.75	0.95	1.92
Filing Date Shares Outstanding	737.45	701.7	697.69	98.12	82.92	335.89
Total Common Shares Outstanding	737.09	701.66	211.09	98.04	82.58	335.89
Working Capital	431.28	169.31	617.93	71.69	67.78	65.86
Book Value Per Share	0.59	0.11	0.60	0.85	0.96	0.23
Tangible Book Value	435.93	75.8	124.86	70.88	65.91	63.78
Tangible Book Value Per Share	0.59	0.11	0.59	0.72	0.80	0.19
Machinery	-	0.92	1.39	1.37	1.56	1.29
Leasehold Improvements	-	0.33	0.81	0.37	0.29	0.25

Source: S&P Capital IQ. Standard template. Financial Sources.